113 related articles for article (PubMed ID: 16184549)
1. Overexpression of PKCepsilon sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1.
Powell CT; Yin L
Int J Cancer; 2006 Mar; 118(6):1572-6. PubMed ID: 16184549
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester-induced apoptosis of C4-2 cells requires both a unique and a redundant protein kinase C signaling pathway.
Yin L; Bennani-Baiti N; Powell CT
J Biol Chem; 2005 Feb; 280(7):5533-41. PubMed ID: 15611126
[TBL] [Abstract][Full Text] [Related]
3. Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase calpha.
Gschwend JE; Fair WR; Powell CT
Mol Pharmacol; 2000 Jun; 57(6):1224-34. PubMed ID: 10825394
[TBL] [Abstract][Full Text] [Related]
4. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.
Powell CT; Brittis NJ; Stec D; Hug H; Heston WD; Fair WR
Cell Growth Differ; 1996 Apr; 7(4):419-28. PubMed ID: 9052983
[TBL] [Abstract][Full Text] [Related]
5. Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.
von Burstin VA; Xiao L; Kazanietz MG
Mol Pharmacol; 2010 Sep; 78(3):325-32. PubMed ID: 20516369
[TBL] [Abstract][Full Text] [Related]
6. Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.
Meshki J; Caino MC; von Burstin VA; Griner E; Kazanietz MG
J Biol Chem; 2010 Aug; 285(34):26033-40. PubMed ID: 20566643
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
Mohanty S; Huang J; Basu A
Clin Cancer Res; 2005 Sep; 11(18):6730-7. PubMed ID: 16166454
[TBL] [Abstract][Full Text] [Related]
8. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
[TBL] [Abstract][Full Text] [Related]
9. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
[TBL] [Abstract][Full Text] [Related]
10. Phorbol-12-myristate 13-acetate acting through protein kinase Cepsilon induces translocator protein (18-kDa) TSPO gene expression.
Batarseh A; Giatzakis C; Papadopoulos V
Biochemistry; 2008 Dec; 47(48):12886-99. PubMed ID: 18975922
[TBL] [Abstract][Full Text] [Related]
11. Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha.
Garcia-Bermejo ML; Leskow FC; Fujii T; Wang Q; Blumberg PM; Ohba M; Kuroki T; Han KC; Lee J; Marquez VE; Kazanietz MG
J Biol Chem; 2002 Jan; 277(1):645-55. PubMed ID: 11584014
[TBL] [Abstract][Full Text] [Related]
12. A protein kinase C/protein kinase D pathway protects LNCaP prostate cancer cells from phorbol ester-induced apoptosis by promoting ERK1/2 and NF-{kappa}B activities.
Chen J; Giridhar KV; Zhang L; Xu S; Wang QJ
Carcinogenesis; 2011 Aug; 32(8):1198-206. PubMed ID: 21665893
[TBL] [Abstract][Full Text] [Related]
13. Some phorbol esters might partially resemble bryostatin 1 in their actions on LNCaP prostate cancer cells and U937 leukemia cells.
Kedei N; Lubart E; Lewin NE; Telek A; Lim L; Mannan P; Garfield SH; Kraft MB; Keck GE; Kolusheva S; Jelinek R; Blumberg PM
Chembiochem; 2011 May; 12(8):1242-51. PubMed ID: 21542090
[TBL] [Abstract][Full Text] [Related]
14. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
Engedal N; Korkmaz CG; Saatcioglu F
Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
[TBL] [Abstract][Full Text] [Related]
15. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
Vrana JA; Saunders AM; Chellappan SP; Grant S
Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer.
Wu D; Foreman TL; Gregory CW; McJilton MA; Wescott GG; Ford OH; Alvey RF; Mohler JL; Terrian DM
Cancer Res; 2002 Apr; 62(8):2423-9. PubMed ID: 11956106
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of bryostatin 1 and phorbol 12-myristate 13-acetate on HOP-92 cell proliferation is mediated by down-regulation of protein kinase Cdelta.
Choi SH; Hyman T; Blumberg PM
Cancer Res; 2006 Jul; 66(14):7261-9. PubMed ID: 16849575
[TBL] [Abstract][Full Text] [Related]
19. Transgenic overexpression of PKCĪµ in the mouse prostate induces preneoplastic lesions.
Benavides F; Blando J; Perez CJ; Garg R; Conti CJ; DiGiovanni J; Kazanietz MG
Cell Cycle; 2011 Jan; 10(2):268-77. PubMed ID: 21224724
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
